Palatin Technologies Inc. (PTN) Trading Update
Palatin Technologies Inc. (PTN) advanced 0.54 % in the 24‑hour period concluding at 03:09 PM Central Europe on Thursday, 22 September 2026. The current trading price on major exchanges is approximately USD 5.55 per share.
The market supply of Palatin shares stands at 1.9 million. With this supply, the company’s market capitalization is USD 10.3 million. In the last 24 hours, trading volume amounted to about USD 113.8 thousand.
Since the end of the previous month, Palatin’s share price has declined 45.96 %. The simple moving average over the last 200 days is USD 14.45. Over the past 52 weeks, the highest recorded price was USD 31 on 15 December 2025, while the lowest price was USD 5.40 on 21 October 2026.
Recent Performance of Peer Companies
| Ticker | 24‑hour Change | Current Price | Market Cap |
|---|---|---|---|
| Nubeva (NBVAF) | 0 % | USD 0.16 | USD 11.9 million |
| Aeon Biopharma (AEON) | +3.45 % | USD 0.24 | USD 11.6 million |
| Air Industries (AIRI) | +1.21 % | USD 2.51 | USD 12.0 million |
| Cellectar Biosciences (CLRB) | +4.07 % | USD 1.28 | USD 12.1 million |
| Clean Energy (CETY) | +3.21 % | USD 0.96 | USD 11.7 million |
Air Industries Group – Q3 2026 Operating Results
Air Industries Group reported third‑quarter operating results that were broadly steady relative to the prior year. Revenue was essentially flat, with a modest decline in telecom service income offset by an increase in international software services. Profitability metrics, including comparable EBITDA and EBIT, slipped slightly, reflecting ongoing cost‑saving initiatives and the impact of a discontinued public‑switched‑telephone network. Cash flow from operations showed a mild contraction, while the debt profile remained stable. The company highlighted progress in data‑center connectivity, noting a significant new contract with a major cloud provider, and reported advancements in artificial‑intelligence‑driven network solutions. Management expressed confidence that strategic transformations would deliver targeted savings and improve efficiency over the year, despite competitive market dynamics and broader economic uncertainties.
Company Overview – Palatin Technologies Inc.
Palatin Technologies Inc. is a biopharmaceutical company focused on developing treatments for male and female sexual dysfunction, congestive heart failure, obesity, and cachexia. The company’s research pipeline includes several investigational products aimed at addressing these conditions.